Related Experiment Video
Updated: Jul 5, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
366
Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy
Noyko Stanilov1, Tsvetelina Velikova2, Spaska Stanilova3
1Medical Faculty, Trakia University, 6000 Stara Zagora, Bulgaria.
International Journal of Molecular Sciences
|January 23, 2024
Summary
Cytokines, crucial immune regulators, play a dual role in cancer initiation and progression. Targeting cytokine signaling pathways offers a promising avenue for innovative cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Cancer is a major global health challenge requiring novel therapeutic strategies.
- Immunotherapies have transformed cancer treatment by leveraging the immune system.
- Cytokines are key immune regulators influencing inflammation and cancer cell behavior.
Purpose of the Study:
- To review the critical role of cytokines in cancer development.
- To explore the therapeutic potential of targeting cytokine signaling pathways.
- To provide an overview of cytokines in cancer therapy.
Main Methods:
- Literature review of scientific articles on cytokines and cancer.
- Analysis of cytokine involvement in cancer initiation, progression, and immune response.
- Examination of cytokine-targeted therapies and signaling pathways.
Main Results:
- Cytokines significantly influence cancer development through inflammation and signaling pathways.
- Dysregulated cytokine activity can promote tumor growth, proliferation, and migration.
- Targeting specific cytokine signaling pathways shows therapeutic promise.
Conclusions:
- Cytokines are pivotal in cancer biology, impacting both disease progression and immune surveillance.
- Modulating cytokine signaling represents a viable strategy for developing effective cancer immunotherapies.
- Further research into cytokine-pathway interactions is essential for advancing cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K